Latest Biomarker Stories
- Treatment with RG-012 Protects Kidney Function and Demonstrates Additive Therapeutic Effect with Emerging Standard of Care in Preclinical Model of Alport Syndrome - LA JOLLA, Calif.,
Results Published in Cancer Epidemiology, Biomarkers & Prevention Demonstrate Utility of Caris Molecular Intelligence(TM) in Exploring Expression of Targetable Immune Proteins IRVING,
HILDEN, Germany, and MANCHESTER, England, November 11, 2014 /PRNewswire/ -- - Master collaboration agreement is a framework for developing and
Study will assess VolitionRx's proprietary Nucleosomics® platform for non-invasive diagnosis of endometriosis NAMUR, Belgium, Nov.
~Data to be presented at the American College of Rheumatology Annual Meeting CHARLOTTESVILLE, Va., Nov.
LOUISVILLE, Ky., Nov. 7, 2014 /PRNewswire/ -- Neuronetrix has been selected by Anavex Life Sciences Corp.
VANCOUVER, Nov. 5, 2014 /PRNewswire/ - Augurex Life Sciences Corp.
BERGEN, Norway, November 4, 2014 /PRNewswire/ -- BerGenBio AS ("BerGenBio" or the "Company"), an oncology biopharmaceutical company, today announces that the first patient
- A person in a secondary role, specifically the second most important character (after the protagonist).
More Images (2 images) »